EPHB2 and colorectal carcinoma: EPHB2 has been associated with the Ras pathway, which in turn is a prominent oncogenic driver in CRC[80], while Eph receptors have been identified to be important in CRC[81], though more studies are necessary for better understanding their specific role in CRC.